Inactive Instrument

News Pardes Biosciences, Inc.

Equities

PRDS

US69945Q1058

Summary

Unlock all the news: Be the first to know and act before the market!

Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from S&P TMI Index	05/09/23	CI
Pardes Biosciences Announces Closing of Tender Offer	31/08/23	AQ
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from NASDAQ Composite Index	31/08/23	CI
MediPacific, Inc. completed the acquisition of Pardes Biosciences, Inc. from a group of shareholders.	30/08/23	CI
Pardes Biosciences Receives Tender Offer for MediPacific Merger Deal	28/08/23	MT
MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences	28/08/23	BU
MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares	17/08/23	BU
PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS	07/08/23	BU
Pardes Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23	CI
PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS	21/07/23	BU
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm	19/07/23	BU
North American Morning Briefing : Earnings -2-	19/07/23	DJ
PRDS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Pardes Biosciences, Inc. Is Fair to Shareholders	17/07/23	BU
Shareholder Alert: Ademi LLP investigates whether Pardes Biosciences, Inc. has obtained a Fair Price in its transaction with MediPacific	17/07/23	PR
Pardes Biosciences Agrees to Be Acquired by MediPacific; Shares Rise	17/07/23	MT
Pardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value Rights	17/07/23	AQ
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell 2500 Value Index	23/06/23	CI
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell Small Cap Comp Value Index	23/06/23	CI
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell 2000 Index	23/06/23	CI
Pardes Biosciences, Inc.(NasdaqGM:PRDS) dropped from Russell 3000 Value Index	23/06/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pardes Biosciences, Inc.

Equities

PRDS

US69945Q1058

Summary

Filters